Skip to Main Content

Paper Details

A feasibility study evaluating lisdexamfetamine dimesylate for the treatment of adults with bulimia nervosa.
Int J Eat Disord
5
2021
Author NameAffiliation
Allan S KaplanInstitute of Medical Science, University of Toronto
Susan L McElroy
Susan L McElroyUniversity of Cincinnati College of Medicine
  • 1 - 3

Datasets

Release 1.2